Results 271 to 280 of about 11,405,950 (406)
CAR-T Cell Therapy for Autoimmune Kidney Diseases: Where Do We Stand Now? [PDF]
Kaleta B.
europepmc +1 more source
Nonclinical evaluation of biological responses to implanted medical devices and combination products in animals is required to predict possible outcomes and risks in patients. This paper describes globally accepted pathology “best practices” that 1) effectively address ISO standards and current regulatory guidance for medical device development and 2 ...
Kathleen A. Funk +6 more
wiley +1 more source
Replicating aging and senescence‐related pathophysiological responses in kidney organoids remains a significant challenge. Human adult renal tubular organoid, tubuloids, are successfully developed recapitulating cellular senescence that is the central pathophysiological mechanism of chronic kidney disease (CKD).
Yuki Nakao +20 more
wiley +1 more source
Fecal microbiota transplantation is a promising therapy for kidney diseases. [PDF]
Zhang J +5 more
europepmc +1 more source
Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats [PDF]
Colby J. Vorland +7 more
openalex +1 more source
Bioprinting Organs—Science or Fiction?—A Review From Students to Students
Bioprinting artificial organs has the potential to revolutionize the medical field. This is a comprehensive review of the bioprinting workflow delving into the latest advancements in bioinks, materials and bioprinting techniques, exploring the critical stages of tissue maturation and functionality.
Nicoletta Murenu +18 more
wiley +1 more source
RNA therapeutics in kidney diseases: prospects and current status. [PDF]
Schena FP, Pasculli E.
europepmc +1 more source
Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: Cohort study [PDF]
Al-Aly, Ziyad +5 more
core +1 more source
Apical PtdIns(4,5)P 2 is required for ciliogenesis and suppression of polycystic kidney disease [PDF]
Wenyan Xu +6 more
openalex +1 more source

